Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorUniversity of Illinois at Urbana-Champaign

About this trial

The study will employ a combined laboratory-ambulatory design. Participants will engage in ambulatory assessment over the course of 14 days, wearing biosensors assessing transdermal alcohol concentration (TAC) and providing breathalyzer readings in real-world contexts. Also during this period, participants will attend three laboratory alcohol-administration sessions scheduled at one-week intervals, with alcohol dose and rate of consumption manipulated within and between participants, respectively. Laboratory visits will also double as ambulatory orientation, check-in, and close-out sessions.

Eligibility criteria

Qualifiers

21 years or older

drink alcohol at least 2x weekly

Disqualifiers

psychological or medical conditions that might contraindicate alcohol-administration

history of adverse reaction to type and amount of beverage used in the study

currently seeking treatment for alcohol use disorder

does not drink alcohol regularly

Trial design

Treatments tested in this trial

  • Alcohol

Treatment groups

No treatment groups listed

Sponsors and collaborators

University of Illinois at Urbana-Champaign

Lead sponsor

National Institutes of Health (NIH)

Collaborator